Akcie: Biotechnologie
Biotechnologické firmy se věnují výzkumu a vývoji nových léčiv, terapií a diagnostických metod, často založených na genetice nebo molekulární biologii. Příjmy mnoha z nich stojí na licenčních smlouvách nebo teprve na budoucím schválení vyvíjených přípravků.
Mezi 517 firmami jsou Vertex Pharmaceuticals a Regeneron Pharmaceuticals, belgicko-nizozemská Argenx, Alnylam Pharmaceuticals specializovaná na RNA terapie i jihokorejská Samsung Biologics.
Úspěch v tomto odvětví silně závisí na výsledcích klinických studií a na schválení regulačními úřady, což z něj dělá jeden z rizikovějších segmentů akciového trhu.
- Počet titulů
- 470
- Celková tržní kapitalizace
- 1,18 bil. USD · 24,96 bil. Kč
- Největší společnost
-
Vertex Pharmaceuticals
Investujte a získejte až 10 000 Kč k prvnímu vkladu.
Chci bonus u eToroeToro je multi-assetová investiční platforma. Hodnota vašich investic může stoupat nebo klesat. Váš kapitál je ohrožen.
| # | Společnost | Cena | Změna 24 h | Tržní kapitalizace |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals VRTX | 528,04 USD | +6,03 % | 125,67 mld. USD 2,66 bil. Kč |
| 2 |  Regeneron Pharmaceuticals REGN | 654,27 USD | +4,73 % | 68,59 mld. USD 1,45 bil. Kč |
| 3 |  Argenx ARGX | 939,68 USD | +3,32 % | 58,73 mld. USD 1,24 bil. Kč |
| 4 |  Alnylam Pharmaceuticals ALNY | 312,78 USD | +3,68 % | 41,76 mld. USD 883,00 mld. Kč |
| 5 |  Samsung Biologics 207940.KS | 1 295 000,00 KRW | +0,70 % | 39,21 mld. USD 829,12 mld. Kč |
| 6 |  CSL CSL.AX | 97,91 AUD | +5,75 % | 32,55 mld. USD 688,28 mld. Kč |
| 7 |  Moderna MRNA | 79,76 USD | +10,01 % | 31,65 mld. USD 669,17 mld. Kč |
| 8 |  Revolution Medicines RVMD | 144,19 USD | −3,58 % | 30,65 mld. USD 648,17 mld. Kč |
| 9 | Revolution Medicines RVMD | 144,19 USD | −3,58 % | 30,65 mld. USD 648,17 mld. Kč |
| 10 |  Celltrion 068270.KS | 192 900,00 KRW | +1,53 % | 27,56 mld. USD 582,71 mld. Kč |
| 11 |  Incyte INCY | 113,75 USD | +5,78 % | 22,73 mld. USD 480,51 mld. Kč |
| 12 |  BioNTech BNTX | 88,81 USD | +3,08 % | 22,46 mld. USD 474,85 mld. Kč |
| 13 |  Insmed INSM | 103,38 USD | −1,04 % | 22,41 mld. USD 473,80 mld. Kč |
| 14 | Insmed INSM | 103,38 USD | −1,04 % | 22,41 mld. USD 473,80 mld. Kč |
| 15 |  WuXi Biologics WXXWY | 8,23 USD | +0,24 % | 17,02 mld. USD 359,78 mld. Kč |
| 16 | Genmab GMAB.CO | 1 636,50 DKK | +0,58 % | 15,37 mld. USD 325,05 mld. Kč |
| 17 |  Jazz Pharmaceuticals JAZZ | 243,47 USD | +2,51 % | 15,28 mld. USD 323,00 mld. Kč |
| 18 |  Exelixis EXEL | 55,85 USD | +3,50 % | 14,04 mld. USD 296,83 mld. Kč |
| 19 |  Ionis Pharmaceuticals IONS | 81,18 USD | +3,63 % | 13,42 mld. USD 283,67 mld. Kč |
| 20 |  BridgeBio Pharma BBIO | 64,68 USD | −4,02 % | 12,67 mld. USD 267,86 mld. Kč |
| 21 |  Axsome Therapeutics AXSM | 244,31 USD | +1,52 % | 12,57 mld. USD 265,83 mld. Kč |
| 22 |  Sino Biopharmaceutical 1177.HK | 4,99 HKD | −1,58 % | 11,35 mld. USD 239,90 mld. Kč |
| 23 |  Arrowhead Pharmaceuticals ARWR | 80,50 USD | +2,04 % | 11,34 mld. USD 239,76 mld. Kč |
| 24 |  Madrigal Pharmaceuticals MDGL | 480,77 USD | +1,37 % | 11,08 mld. USD 234,38 mld. Kč |
| 25 |  Bio-Techne TECH | 71,00 USD | +0,42 % | 11,06 mld. USD 233,91 mld. Kč |
| 26 |  BioMarin Pharmaceutical BMRN | 57,01 USD | −3,38 % | 11,02 mld. USD 232,97 mld. Kč |
| 27 |  Krystal Biotech KRYS | 372,25 USD | +3,42 % | 10,97 mld. USD 232,04 mld. Kč |
| 28 | Apogee Therapeutics APGE | 132,55 USD | −0,10 % | 9,97 mld. USD 210,72 mld. Kč |
| 29 |  Halozyme Therapeutics HALO | 76,89 USD | +2,57 % | 9,12 mld. USD 192,84 mld. Kč |
| 30 |  TG Therapeutics TGTX | 55,83 USD | +4,10 % | 8,55 mld. USD 180,71 mld. Kč |
| 31 |  Protagonist Therapeutics PTGX | 131,62 USD | +5,15 % | 8,46 mld. USD 178,98 mld. Kč |
| 32 |  Nuvalent NUVL | 104,26 USD | +2,75 % | 8,23 mld. USD 174,11 mld. Kč |
| 33 |  Corcept Therapeutics CORT | 73,86 USD | +1,71 % | 7,93 mld. USD 167,65 mld. Kč |
| 34 |  ImmunityBio IBRX | 7,20 USD | +3,15 % | 7,54 mld. USD 159,45 mld. Kč |
| 35 |  Cytokinetics CYTK | 86,49 USD | +1,44 % | 7,40 mld. USD 156,51 mld. Kč |
| 36 |  Praxis Precision Medicines PRAX | 264,75 USD | −5,08 % | 7,38 mld. USD 156,07 mld. Kč |
| 37 |  Vaxcyte PCVX | 45,42 USD | −3,11 % | 6,56 mld. USD 138,68 mld. Kč |
| 38 |  Mirum Pharmaceuticals MIRM | 106,17 USD | −0,92 % | 6,47 mld. USD 136,90 mld. Kč |
| 39 |  Kymera Therapeutics KYMR | 78,23 USD | +1,72 % | 6,44 mld. USD 136,07 mld. Kč |
| 40 |  Ligand Pharmaceuticals LGND | 312,01 USD | −1,29 % | 6,25 mld. USD 132,22 mld. Kč |
| 41 |  Centessa Pharmaceuticals CNTA | 39,75 USD | −0,15 % | 6,15 mld. USD 130,05 mld. Kč |
| 42 |  Biocon BIOCON.NS | 426,80 INR | +1,96 % | 6,11 mld. USD 129,12 mld. Kč |
| 43 |  Belite Bio BLTE | 152,72 USD | −1,39 % | 6,10 mld. USD 129,06 mld. Kč |
| 44 |  PTC Therapeutics PTCT | 70,97 USD | +0,47 % | 5,89 mld. USD 124,48 mld. Kč |
| 45 |  Legend Biotech LEGN | 28,88 USD | −1,74 % | 5,59 mld. USD 118,12 mld. Kč |
| 46 |  Scholar Rock Holding SRRK | 46,48 USD | +0,24 % | 5,55 mld. USD 117,25 mld. Kč |
| 47 |  Immunovant IMVT | 27,22 USD | −5,06 % | 5,54 mld. USD 117,14 mld. Kč |
| 48 |  Travere Therapeutics TVTX | 56,34 USD | −0,83 % | 5,24 mld. USD 110,78 mld. Kč |
| 49 |  Xenon Pharmaceuticals XENE | 51,21 USD | −1,01 % | 4,95 mld. USD 104,67 mld. Kč |
| 50 |  CRISPR Therapeutics CRSP | 49,80 USD | −0,86 % | 4,90 mld. USD 103,70 mld. Kč |
| 51 | Magenta Therapeutics DNTH | 86,66 USD | +1,39 % | 4,74 mld. USD 100,17 mld. Kč |
| 52 |  Genscript Biotech 1548.HK | 15,28 HKD | +0,46 % | 4,26 mld. USD 89,98 mld. Kč |
| 53 |  Denali Therapeutics DNLI | 25,72 USD | −0,66 % | 4,08 mld. USD 86,31 mld. Kč |
| 54 |  ACADIA Pharmaceuticals ACAD | 21,56 USD | −0,74 % | 3,69 mld. USD 78,06 mld. Kč |
| 55 | ACADIA Pharmaceuticals ACAD | 21,56 USD | −0,74 % | 3,69 mld. USD 78,06 mld. Kč |
| 56 |  Hualan Biological Engineering 002007.SZ | 13,42 CNY | +1,74 % | 3,61 mld. USD 76,36 mld. Kč |
| 57 |  Viking Therapeutics VKTX | 30,00 USD | −3,78 % | 3,48 mld. USD 73,52 mld. Kč |
| 58 |  Adaptive Biotechnologies ADPT | 20,96 USD | +3,51 % | 3,35 mld. USD 70,93 mld. Kč |
| 59 | Edgewise Therapeutics EWTX | 39,56 USD | +1,05 % | 3,33 mld. USD 70,39 mld. Kč |
| 60 | Tango Therapeutics TNGX | 23,02 USD | −1,96 % | 3,32 mld. USD 70,21 mld. Kč |
| 61 | Tango Therapeutics TNGX | 23,02 USD | −1,96 % | 3,32 mld. USD 70,21 mld. Kč |
| 62 |  Ultragenyx RARE | 33,47 USD | +3,37 % | 3,30 mld. USD 69,70 mld. Kč |
| 63 | Ultragenyx RARE | 33,47 USD | +3,37 % | 3,30 mld. USD 69,70 mld. Kč |
| 64 | Newamsterdam Pharma NAMS | 34,83 USD | −0,97 % | 3,28 mld. USD 69,33 mld. Kč |
| 65 |  Beam Therapeutics BEAM | 31,64 USD | +0,54 % | 3,25 mld. USD 68,74 mld. Kč |
| 66 | Beam Therapeutics BEAM | 31,64 USD | +0,54 % | 3,25 mld. USD 68,74 mld. Kč |
| 67 | Dyne Therapeutics DYN | 19,33 USD | +4,15 % | 3,20 mld. USD 67,57 mld. Kč |
| 68 | Dyne Therapeutics DYN | 19,33 USD | +4,15 % | 3,20 mld. USD 67,57 mld. Kč |
| 69 |  Erasca ERAS | 10,12 USD | −2,69 % | 3,15 mld. USD 66,54 mld. Kč |
| 70 | Telix Pharmaceuticals TLX.AX | 13,31 AUD | +3,26 % | 3,13 mld. USD 66,19 mld. Kč |
| 71 |  Arcus Biosciences RCUS | 23,30 USD | +5,33 % | 2,93 mld. USD 61,96 mld. Kč |
| 72 | Arcus Biosciences RCUS | 23,30 USD | +5,33 % | 2,93 mld. USD 61,96 mld. Kč |
| 73 |  IDEAYA Biosciences IDYA | 30,59 USD | +0,07 % | 2,89 mld. USD 61,19 mld. Kč |
| 74 |  BB Biotech BION.SW | 42,05 CHF | +1,57 % | 2,89 mld. USD 61,06 mld. Kč |
| 75 |  uniQure QURE | 41,81 USD | −7,44 % | 2,87 mld. USD 60,78 mld. Kč |
| 76 |  Arcutis Biotherapeutics ARQT | 22,33 USD | +3,64 % | 2,79 mld. USD 59,05 mld. Kč |
| 77 | Structure Therapeutics GPCR | 38,32 USD | −1,99 % | 2,72 mld. USD 57,59 mld. Kč |
| 78 |  Vera Therapeutics VERA | 41,20 USD | −3,42 % | 2,67 mld. USD 56,53 mld. Kč |
| 79 | Tarsus Pharmaceuticals TARS | 61,16 USD | −1,77 % | 2,63 mld. USD 55,64 mld. Kč |
| 80 | Tarsus Pharmaceuticals TARS | 61,16 USD | −1,77 % | 2,63 mld. USD 55,64 mld. Kč |
| 81 | Disc Medicine IRON | 68,26 USD | +1,08 % | 2,61 mld. USD 55,13 mld. Kč |
| 82 | Enliven Therapeutics ELVN | 41,70 USD | +1,14 % | 2,54 mld. USD 53,69 mld. Kč |
| 83 |  Relay Therapeutics RLAY | 12,76 USD | +2,00 % | 2,44 mld. USD 51,69 mld. Kč |
| 84 | Relay Therapeutics RLAY | 12,76 USD | +2,00 % | 2,44 mld. USD 51,69 mld. Kč |
| 85 |  Biohaven Pharmaceutical BHVN | 15,83 USD | +3,19 % | 2,38 mld. USD 50,40 mld. Kč |
| 86 |  Pharvaris PHVS | 33,86 USD | −0,27 % | 2,37 mld. USD 50,03 mld. Kč |
| 87 | Mineralys Therapeutics MLYS | 26,68 USD | +1,29 % | 2,35 mld. USD 49,73 mld. Kč |
| 88 |  ADMA Biologics ADMA | 10,08 USD | −1,66 % | 2,34 mld. USD 49,52 mld. Kč |
| 89 |  Intellia Therapeutics NTLA | 16,68 USD | +4,05 % | 2,33 mld. USD 49,28 mld. Kč |
| 90 |  Vericel VCEL | 45,07 USD | −2,51 % | 2,30 mld. USD 48,67 mld. Kč |
| 91 | Vericel VCEL | 45,07 USD | −2,51 % | 2,30 mld. USD 48,67 mld. Kč |
| 92 |  Kodiak Sciences KOD | 35,94 USD | +5,43 % | 2,25 mld. USD 47,56 mld. Kč |
| 93 |  Maravai LifeSciences MRVI | 6,04 USD | −1,79 % | 2,23 mld. USD 47,11 mld. Kč |
| 94 |  AnaptysBio ANAB | 63,42 USD | −3,07 % | 2,20 mld. USD 46,54 mld. Kč |
| 95 |  Aurinia Pharmaceuticals AUPH | 16,25 USD | +1,28 % | 2,11 mld. USD 44,63 mld. Kč |
| 96 |  Genus GNS.L | 2 364,00 GBp | +3,41 % | 2,10 mld. USD 44,34 mld. Kč |
| 97 | Immunome IMNM | 18,36 USD | +1,10 % | 2,08 mld. USD 43,97 mld. Kč |
| 98 |  Zai Lab ZLAB | 18,39 USD | −6,95 % | 2,07 mld. USD 43,69 mld. Kč |
| 99 |  Harmony Biosciences HRMY | 35,48 USD | +4,05 % | 2,05 mld. USD 43,43 mld. Kč |
| 100 | Harmony Biosciences HRMY | 35,48 USD | +4,05 % | 2,05 mld. USD 43,43 mld. Kč |
| 101 | Tyra Biosciences TYRA | 30,62 USD | +4,11 % | 2,04 mld. USD 43,10 mld. Kč |
| 102 |  Nektar Therapeutics NKTR | 59,23 USD | +1,14 % | 2,00 mld. USD 42,31 mld. Kč |
| 103 | Taysha Gene Therapies TSHA | 6,83 USD | +2,40 % | 1,96 mld. USD 41,50 mld. Kč |
| 104 | Taysha Gene Therapies TSHA | 6,83 USD | +2,40 % | 1,96 mld. USD 41,50 mld. Kč |
| 105 |  Inhibrx INBX | 134,35 USD | +7,89 % | 1,96 mld. USD 41,50 mld. Kč |
| 106 |  Ocular Therapeutix OCUL | 8,80 USD | +5,39 % | 1,93 mld. USD 40,74 mld. Kč |
| 107 | Mesoblast MSB.AX | 2,11 AUD | +2,93 % | 1,89 mld. USD 40,04 mld. Kč |
| 108 |  Syndax Pharmaceuticals SNDX | 20,65 USD | +2,74 % | 1,83 mld. USD 38,69 mld. Kč |
| 109 |  Sarepta Therapeutics SRPT | 16,85 USD | +5,18 % | 1,78 mld. USD 37,62 mld. Kč |
| 110 |  Zymeworks ZYME | 24,15 USD | +1,60 % | 1,78 mld. USD 37,57 mld. Kč |
| 111 |  Iovance Biotherapeutics IOVA | 3,97 USD | −4,57 % | 1,77 mld. USD 37,48 mld. Kč |
| 112 |  ATAI Life Sciences ATAI | 4,81 USD | −1,36 % | 1,77 mld. USD 37,47 mld. Kč |
| 113 | Oculis Holding OCS | 30,55 USD | −6,43 % | 1,77 mld. USD 37,46 mld. Kč |
| 114 |  Innoviva INVA | 23,07 USD | +2,35 % | 1,70 mld. USD 36,00 mld. Kč |
| 115 |  Recursion Pharmaceuticals RXRX | 3,18 USD | −3,34 % | 1,69 mld. USD 35,69 mld. Kč |
| 116 |  Capricor Therapeutics CAPR | 29,14 USD | −0,75 % | 1,69 mld. USD 35,68 mld. Kč |
| 117 | Nurix Therapeutics NRIX | 16,28 USD | −3,55 % | 1,68 mld. USD 35,60 mld. Kč |
| 118 | Nurix Therapeutics NRIX | 16,28 USD | −3,55 % | 1,68 mld. USD 35,60 mld. Kč |
| 119 |  Agios Pharmaceuticals AGIO | 28,28 USD | +0,50 % | 1,68 mld. USD 35,56 mld. Kč |
| 120 | Nanobiotix NBTX | 38,40 USD | −2,74 % | 1,68 mld. USD 35,50 mld. Kč |
| 121 | Nanobiotix NBTX | 38,40 USD | −2,74 % | 1,68 mld. USD 35,50 mld. Kč |
| 122 |  Nuvation Bio NUVB | 4,79 USD | −0,42 % | 1,67 mld. USD 35,27 mld. Kč |
| 123 |  Vir Biotechnology VIR | 9,54 USD | −0,10 % | 1,61 mld. USD 34,02 mld. Kč |
| 124 |  Ardelyx ARDX | 5,69 USD | −1,73 % | 1,56 mld. USD 33,08 mld. Kč |
| 125 | Monte Rosa Therapeutics GLUE | 17,93 USD | −0,44 % | 1,51 mld. USD 32,03 mld. Kč |
| 126 |  Novavax NVAX | 9,13 USD | −3,89 % | 1,50 mld. USD 31,74 mld. Kč |
| 127 | Novavax NVAX | 9,13 USD | −3,89 % | 1,50 mld. USD 31,74 mld. Kč |
| 128 | GH Research PLC GHRS | 21,01 USD | −6,37 % | 1,44 mld. USD 30,46 mld. Kč |
| 129 |  Immunocore IMCR | 28,04 USD | −2,50 % | 1,43 mld. USD 30,16 mld. Kč |
| 130 | Fortrea FTRE | 14,99 USD | −2,85 % | 1,42 mld. USD 29,98 mld. Kč |
| 131 |  Precigen PGEN | 5,64 USD | +7,43 % | 1,41 mld. USD 29,82 mld. Kč |
| 132 |  AbCellera Biologics ABCL | 4,51 USD | +1,69 % | 1,38 mld. USD 29,08 mld. Kč |
| 133 |  Immatics IMTX | 9,78 USD | +2,73 % | 1,34 mld. USD 28,26 mld. Kč |
| 134 |  Corvus Pharmaceuticals CRVS | 15,81 USD | +1,67 % | 1,33 mld. USD 28,11 mld. Kč |
| 135 | Olema Pharmaceuticals OLMA | 14,92 USD | +0,13 % | 1,30 mld. USD 27,56 mld. Kč |
| 136 | Olema Pharmaceuticals OLMA | 14,92 USD | +0,13 % | 1,30 mld. USD 27,56 mld. Kč |
| 137 | Moonlake Immunotherapeutics MLTX | 17,58 USD | +5,08 % | 1,28 mld. USD 27,08 mld. Kč |
| 138 | Moonlake Immunotherapeutics MLTX | 17,58 USD | +5,08 % | 1,28 mld. USD 27,08 mld. Kč |
| 139 |  ORIC Pharmaceuticals ORIC | 11,64 USD | +6,89 % | 1,20 mld. USD 25,48 mld. Kč |
| 140 | Neuren Pharmaceuticals NEU.AX | 13,39 AUD | +0,60 % | 1,17 mld. USD 24,83 mld. Kč |
| 141 | Absci ABSI | 7,41 USD | +3,20 % | 1,16 mld. USD 24,43 mld. Kč |
| 142 |  EyePoint Pharmaceuticals EYPT | 13,62 USD | −2,58 % | 1,14 mld. USD 24,15 mld. Kč |
| 143 |  Savara Pharmaceuticals SVRA | 5,28 USD | +0,09 % | 1,08 mld. USD 22,86 mld. Kč |
| 144 | Oxford Biomedica OXB.L | 647,00 GBp | −0,31 % | 1,04 mld. USD 22,09 mld. Kč |
| 145 | Inventiva IVA | 3,91 USD | +5,96 % | 1,04 mld. USD 22,00 mld. Kč |
| 146 |  MannKind Corp MNKD | 3,36 USD | −4,55 % | 1,04 mld. USD 21,95 mld. Kč |
| 147 |  Xeris Pharmaceuticals XERS | 5,92 USD | −1,50 % | 1,02 mld. USD 21,61 mld. Kč |
| 148 |  Geron GERN | 1,36 USD | +7,09 % | 980,58 mil. USD 20,73 mld. Kč |
| 149 |  Lexicon Pharmaceuticals LXRX | 2,16 USD | −3,14 % | 959,46 mil. USD 20,29 mld. Kč |
| 150 |  Janux Therapeutics JANX | 15,54 USD | +6,00 % | 947,70 mil. USD 20,04 mld. Kč |
| 151 |  Xencor XNCR | 15,00 USD | −2,47 % | 942,77 mil. USD 19,93 mld. Kč |
| 152 | Cullinan Management CGEM | 14,73 USD | +1,24 % | 905,28 mil. USD 19,14 mld. Kč |
| 153 | Annexon Biosciences ANNX | 5,46 USD | −1,62 % | 894,58 mil. USD 18,92 mld. Kč |
| 154 | Annexon Biosciences ANNX | 5,46 USD | −1,62 % | 894,58 mil. USD 18,92 mld. Kč |
| 155 |  MeiraGTx MGTX | 9,59 USD | −0,10 % | 888,13 mil. USD 18,78 mld. Kč |
| 156 | Vor Biopharma VOR | 16,36 USD | +1,74 % | 886,48 mil. USD 18,74 mld. Kč |
| 157 |  Sellas Life Sciences SLS | 14,98 USD | +12,89 % | 870,99 mil. USD 18,42 mld. Kč |
| 158 |  Theravance Biopharma TBPH | 16,93 USD | −0,29 % | 865,60 mil. USD 18,30 mld. Kč |
| 159 |  Arbutus Biopharma ABUS | 4,34 USD | −0,23 % | 854,72 mil. USD 18,07 mld. Kč |
| 160 | Ars Pharmaceuticals SPRY | 8,56 USD | +7,81 % | 850,04 mil. USD 17,97 mld. Kč |
| 161 |  Design Therapeutics DSGN | 15,64 USD | +6,68 % | 849,41 mil. USD 17,96 mld. Kč |
| 162 | PYC Therapeutics PYC.AX | 1,24 AUD | −2,76 % | 843,20 mil. USD 17,83 mld. Kč |
| 163 |  Kura Oncology KURA | 9,42 USD | +1,07 % | 836,14 mil. USD 17,68 mld. Kč |
| 164 |  Phathom Pharmaceuticals PHAT | 10,32 USD | −3,91 % | 823,08 mil. USD 17,40 mld. Kč |
| 165 | Zevra Therapeutics ZVRA | 13,81 USD | −3,70 % | 816,38 mil. USD 17,26 mld. Kč |
| 166 |  Sana Biotechnology SANA | 2,87 USD | +1,77 % | 798,70 mil. USD 16,89 mld. Kč |
| 167 |  Replimune REPL | 9,47 USD | −4,05 % | 781,96 mil. USD 16,53 mld. Kč |
| 168 |  PeptiDream 4587.T | 976,60 JPY | +3,75 % | 777,57 mil. USD 16,44 mld. Kč |
| 169 |  Allogene Therapeutics ALLO | 2,22 USD | +3,99 % | 764,52 mil. USD 16,17 mld. Kč |
| 170 |  Alpha Tau Medical DRTS | 8,34 USD | +13,16 % | 734,00 mil. USD 15,52 mld. Kč |
| 171 |  Solid Biosciences SLDB | 7,34 USD | +3,82 % | 722,62 mil. USD 15,28 mld. Kč |
| 172 |  CytomX Therapeutics CTMX | 3,18 USD | −1,24 % | 692,30 mil. USD 14,64 mld. Kč |
| 173 |  Cormedix CRMD | 8,74 USD | −2,46 % | 685,67 mil. USD 14,50 mld. Kč |
| 174 |  Ginkgo Bioworks DNA | 10,21 USD | −0,39 % | 666,96 mil. USD 14,10 mld. Kč |
| 175 |  Sutro Biopharma STRO | 40,24 USD | +1,03 % | 666,69 mil. USD 14,10 mld. Kč |
| 176 |  Aura Biosciences AURA | 6,41 USD | +3,22 % | 662,71 mil. USD 14,01 mld. Kč |
| 177 |  Altimmune ALT | 3,16 USD | +0,32 % | 614,54 mil. USD 12,99 mld. Kč |
| 178 |  Rigel Pharmaceuticals RIGL | 32,91 USD | −1,38 % | 608,90 mil. USD 12,87 mld. Kč |
| 179 | Opthea OPT.AX | 0,60 AUD | +0,00 % | 569,79 mil. USD 12,05 mld. Kč |
| 180 | Shattuck Labs STTK | 7,05 USD | +8,29 % | 538,14 mil. USD 11,38 mld. Kč |
| 181 | Shattuck Labs STTK | 7,05 USD | +8,29 % | 538,14 mil. USD 11,38 mld. Kč |
| 182 | Prokidney PROK | 1,75 USD | −1,69 % | 528,43 mil. USD 11,17 mld. Kč |
| 183 |  REGENXBIO RGNX | 10,22 USD | +10,85 % | 527,53 mil. USD 11,15 mld. Kč |
| 184 |  Ovid Therapeutics OVID | 2,80 USD | +0,00 % | 522,59 mil. USD 11,05 mld. Kč |
| 185 |  Arvinas ARVN | 8,07 USD | −2,95 % | 520,36 mil. USD 11,00 mld. Kč |
| 186 | Valneva VLA.PA | 2,34 EUR | +4,10 % | 507,05 mil. USD 10,72 mld. Kč |
| 187 |  Achieve Life Sciences ACHV | 4,91 USD | −8,40 % | 504,06 mil. USD 10,66 mld. Kč |
| 188 |  Ocugen OCGN | 1,48 USD | −3,27 % | 501,01 mil. USD 10,59 mld. Kč |
| 189 | Zura Bio ZURA | 5,17 USD | +3,30 % | 490,53 mil. USD 10,37 mld. Kč |
| 190 |  C4 Therapeutics CCCC | 4,30 USD | −0,92 % | 475,44 mil. USD 10,05 mld. Kč |
| 191 | Immix Biopharma IMMX | 10,34 USD | +5,19 % | 472,34 mil. USD 9,99 mld. Kč |
| 192 | 4D Molecular Therapeutics FDMT | 13,00 USD | +2,44 % | 460,54 mil. USD 9,74 mld. Kč |
| 193 | 4D Molecular Therapeutics FDMT | 13,00 USD | +2,44 % | 460,54 mil. USD 9,74 mld. Kč |
| 194 |  Prothena PRTA | 8,79 USD | −4,97 % | 460,18 mil. USD 9,73 mld. Kč |
| 195 | Candel Therapeutics CADL | 9,83 USD | −0,51 % | 452,67 mil. USD 9,57 mld. Kč |
| 196 |  Lyell Immunopharma LYEL | 19,33 USD | −3,64 % | 451,05 mil. USD 9,54 mld. Kč |
| 197 |  Atea Pharmaceuticals AVIR | 5,54 USD | −1,95 % | 443,35 mil. USD 9,37 mld. Kč |
| 198 | Sagimet Biosciences SGMT | 7,06 USD | +2,92 % | 435,97 mil. USD 9,22 mld. Kč |
| 199 |  ADC Therapeutics SA ADCT | 3,43 USD | −0,15 % | 435,63 mil. USD 9,21 mld. Kč |
| 200 | ADC Therapeutics SA ADCT | 3,43 USD | −0,15 % | 435,63 mil. USD 9,21 mld. Kč |
| 201 | ADC Therapeutics ADCT | 3,43 USD | −0,15 % | 435,63 mil. USD 9,21 mld. Kč |
| 202 |  PureTech Health PRTC | 17,42 USD | +0,99 % | 424,03 mil. USD 8,97 mld. Kč |
| 203 | Eupraxia Pharmaceuticals EPRX.TO | 9,17 CAD | +3,97 % | 421,88 mil. USD 8,92 mld. Kč |
| 204 | Autolus Therapeutics AUTL | 1,58 USD | +0,64 % | 420,51 mil. USD 8,89 mld. Kč |
| 205 |  Benitec Biopharma BNTC | 12,15 USD | +2,97 % | 417,41 mil. USD 8,83 mld. Kč |
| 206 | Avacta AVCT.L | 68,30 GBp | −3,12 % | 415,16 mil. USD 8,78 mld. Kč |
| 207 |  Verastem Oncology VSTM | 4,71 USD | −0,21 % | 413,88 mil. USD 8,75 mld. Kč |
| 208 | Formycon FYB.DE | 20,25 EUR | +3,85 % | 409,43 mil. USD 8,66 mld. Kč |
| 209 | Century Therapeutics IPSC | 2,43 USD | +1,67 % | 396,78 mil. USD 8,39 mld. Kč |
| 210 |  Rocket Pharmaceuticals RCKT | 3,42 USD | +1,48 % | 373,44 mil. USD 7,90 mld. Kč |
| 211 |  Nautilus Biotechnology NAUT | 2,93 USD | −2,98 % | 372,34 mil. USD 7,87 mld. Kč |
| 212 |  X4 Pharmaceuticals XFOR | 3,85 USD | +3,77 % | 363,13 mil. USD 7,68 mld. Kč |
| 213 |  Vanda Pharmaceuticals VNDA | 6,01 USD | +2,74 % | 361,41 mil. USD 7,64 mld. Kč |
| 214 | Surrozen SRZN | 30,75 USD | −9,90 % | 357,02 mil. USD 7,55 mld. Kč |
| 215 | Surrozen SRZN | 30,75 USD | −9,90 % | 357,02 mil. USD 7,55 mld. Kč |
| 216 |  Enanta Pharmaceuticals ENTA | 11,90 USD | +3,39 % | 346,03 mil. USD 7,32 mld. Kč |
| 217 | Neumora Therapeutics NMRA | 1,83 USD | −5,67 % | 339,07 mil. USD 7,17 mld. Kč |
| 218 | Race Oncology RAC.AX | 2,29 AUD | +0,44 % | 336,81 mil. USD 7,12 mld. Kč |
| 219 | Bicycle Therapeutics BCYC | 4,81 USD | −1,64 % | 335,79 mil. USD 7,10 mld. Kč |
| 220 | Clinuvel Pharmaceuticals CUV.AX | 9,54 AUD | +2,03 % | 333,97 mil. USD 7,06 mld. Kč |
| 221 |  Cellectis CLLS | 3,30 USD | +12,44 % | 332,02 mil. USD 7,02 mld. Kč |
| 222 | Immuneering IMRX | 5,05 USD | +1,20 % | 326,72 mil. USD 6,91 mld. Kč |
| 223 |  Zentalis Pharmaceuticals ZNTL | 4,46 USD | +2,41 % | 317,49 mil. USD 6,71 mld. Kč |
| 224 | Zentalis Pharmaceuticals ZNTL | 4,46 USD | +2,41 % | 317,49 mil. USD 6,71 mld. Kč |
| 225 | Silence Therapeutics SLN | 6,71 USD | −4,14 % | 316,94 mil. USD 6,70 mld. Kč |
| 226 |  Lineage Cell Therapeutics LCTX | 1,27 USD | −0,78 % | 316,61 mil. USD 6,69 mld. Kč |
| 227 |  Abeona Therapeutics ABEO | 5,53 USD | +0,00 % | 315,18 mil. USD 6,66 mld. Kč |
| 228 | Sab Biotherapeutics SABS | 4,09 USD | +7,63 % | 287,43 mil. USD 6,08 mld. Kč |
| 229 | NervGen Pharma NGEN | 2,12 USD | +1,44 % | 287,29 mil. USD 6,07 mld. Kč |
| 230 |  Editas Medicine EDIT | 2,90 USD | −1,02 % | 283,93 mil. USD 6,00 mld. Kč |
| 231 | Scancell SCLP.L | 20,00 GBp | +8,11 % | 277,21 mil. USD 5,86 mld. Kč |
| 232 | Foghorn Therapeutics FHTX | 4,70 USD | −1,26 % | 275,89 mil. USD 5,83 mld. Kč |
| 233 | Foghorn Therapeutics FHTX | 4,70 USD | −1,26 % | 275,89 mil. USD 5,83 mld. Kč |
| 234 | Greenwich LifeSciences GLSI | 18,33 USD | −14,51 % | 269,05 mil. USD 5,69 mld. Kč |
| 235 | Greenwich LifeSciences GLSI | 18,33 USD | −14,51 % | 269,05 mil. USD 5,69 mld. Kč |
| 236 | Prelude Therapeutics PRLD | 4,91 USD | +0,00 % | 268,43 mil. USD 5,68 mld. Kč |
| 237 |  Entrada Therapeutics TRDA | 6,83 USD | −6,69 % | 265,14 mil. USD 5,61 mld. Kč |
| 238 | Invivyd IVVD | 0,89 USD | +1,47 % | 262,70 mil. USD 5,55 mld. Kč |
| 239 | Adagene ADAG | 3,97 USD | +0,76 % | 262,31 mil. USD 5,55 mld. Kč |
| 240 |  Compugen CGEN | 2,71 USD | +1,88 % | 256,24 mil. USD 5,42 mld. Kč |
| 241 |  Arcturus Therapeutics ARCT | 8,90 USD | −2,52 % | 252,97 mil. USD 5,35 mld. Kč |
| 242 |  ProQR PRQR | 1,81 USD | +3,43 % | 249,94 mil. USD 5,28 mld. Kč |
| 243 | Orchestra Biomed OBIO | 4,10 USD | +0,74 % | 245,51 mil. USD 5,19 mld. Kč |
| 244 | ALX Oncology Holdings ALXO | 1,80 USD | −4,01 % | 241,54 mil. USD 5,11 mld. Kč |
| 245 |  AC Immune ACIU | 2,36 USD | +0,85 % | 240,19 mil. USD 5,08 mld. Kč |
| 246 |  InflaRx IFRX | 1,62 USD | −2,41 % | 238,61 mil. USD 5,05 mld. Kč |
| 247 |  Minerva Neurosciences NERV | 5,10 USD | −0,97 % | 237,60 mil. USD 5,02 mld. Kč |
| 248 |  Anavex Life Sciences AVXL | 2,55 USD | −6,59 % | 236,31 mil. USD 5,00 mld. Kč |
| 249 |  Keros Therapeutics KROS | 11,82 USD | +1,50 % | 233,79 mil. USD 4,94 mld. Kč |
| 250 | Inhibikase Therapeutics IKT | 1,74 USD | +3,57 % | 229,74 mil. USD 4,86 mld. Kč |
| 251 |  Alector ALEC | 2,06 USD | +2,49 % | 228,71 mil. USD 4,84 mld. Kč |
| 252 |  Coherus BioSciences CHRS | 1,44 USD | +2,86 % | 222,12 mil. USD 4,70 mld. Kč |
| 253 | Starpharma SPL.AX | 0,74 AUD | +2,08 % | 214,77 mil. USD 4,54 mld. Kč |
| 254 |  Immunic IMUX | 15,30 USD | +1,53 % | 208,41 mil. USD 4,41 mld. Kč |
| 255 |  Codexis CDXS | 2,25 USD | −0,88 % | 204,52 mil. USD 4,32 mld. Kč |
| 256 |  Humacyte HUMA | 0,76 USD | +21,93 % | 203,90 mil. USD 4,31 mld. Kč |
| 257 |  Avidity Biosciences RNA | 13,14 USD | −0,83 % | 203,87 mil. USD 4,31 mld. Kč |
| 258 |  Voyager Therapeutics VYGR | 3,33 USD | −8,01 % | 201,20 mil. USD 4,25 mld. Kč |
| 259 |  Karyopharm Therapeutics KPTI | 8,81 USD | +1,97 % | 198,68 mil. USD 4,20 mld. Kč |
| 260 |  Tonix Pharmaceuticals TNXP | 12,34 USD | −0,80 % | 196,71 mil. USD 4,16 mld. Kč |
| 261 | Elicio Therapeutics ELTX | 3,22 USD | −37,35 % | 195,37 mil. USD 4,13 mld. Kč |
| 262 | Acumen Pharmaceuticals ABOS | 2,57 USD | +0,39 % | 185,62 mil. USD 3,92 mld. Kč |
| 263 |  Innate Pharma IPH.PA | 1,66 EUR | +4,00 % | 178,76 mil. USD 3,78 mld. Kč |
| 264 | Caribou Biosciences CRBU | 1,79 USD | −2,72 % | 177,53 mil. USD 3,75 mld. Kč |
| 265 |  Protalix BioTherapeutics PLX | 2,32 USD | +0,87 % | 175,65 mil. USD 3,71 mld. Kč |
| 266 | Nkarta NKTX | 2,44 USD | −0,41 % | 174,57 mil. USD 3,69 mld. Kč |
| 267 | Nkarta NKTX | 2,44 USD | −0,41 % | 174,57 mil. USD 3,69 mld. Kč |
| 268 |  Heron Therapeutics HRTX | 0,92 USD | +0,28 % | 173,57 mil. USD 3,67 mld. Kč |
| 269 | Tenaya Therapeutics TNYA | 0,79 USD | +5,50 % | 170,76 mil. USD 3,61 mld. Kč |
| 270 | Orthocell OCC.AX | 0,86 AUD | +0,58 % | 162,24 mil. USD 3,43 mld. Kč |
| 271 |  Milestone Pharmaceuticals MIST | 1,30 USD | −0,76 % | 161,85 mil. USD 3,42 mld. Kč |
| 272 |  Agenus AGEN | 3,89 USD | +3,60 % | 161,38 mil. USD 3,41 mld. Kč |
| 273 |  Molecular Partners MOLN | 4,20 USD | +4,92 % | 157,54 mil. USD 3,33 mld. Kč |
| 274 |  Precision BioSciences DTIL | 6,10 USD | −1,13 % | 157,39 mil. USD 3,33 mld. Kč |
| 275 |  Fate Therapeutics FATE | 2,92 USD | −3,31 % | 155,79 mil. USD 3,29 mld. Kč |
| 276 | Fate Therapeutics FATE | 2,92 USD | −3,31 % | 155,79 mil. USD 3,29 mld. Kč |
| 277 | Spruce Biosciences SPRB | 57,05 USD | +0,85 % | 154,17 mil. USD 3,26 mld. Kč |
| 278 |  AN2 Therapeutics ANTX | 4,27 USD | −9,53 % | 153,70 mil. USD 3,25 mld. Kč |
| 279 |  Corbus Pharmaceuticals CRBP | 8,19 USD | +5,27 % | 151,74 mil. USD 3,21 mld. Kč |
| 280 |  Galectin Therapeutics GALT | 2,27 USD | +0,89 % | 149,43 mil. USD 3,16 mld. Kč |
| 281 |  Spero Therapeutics SPRO | 2,56 USD | +1,99 % | 148,23 mil. USD 3,13 mld. Kč |
| 282 | Unicycive Therapeutics UNCY | 5,28 USD | +12,58 % | 144,64 mil. USD 3,06 mld. Kč |
| 283 |  Vaxart VXRT | 0,57 USD | −1,72 % | 137,97 mil. USD 2,92 mld. Kč |
| 284 | Connect Biopharma Holdings CNTB | 2,17 USD | −5,65 % | 136,63 mil. USD 2,89 mld. Kč |
| 285 | Rani Therapeutics RANI | 1,07 USD | +10,82 % | 133,65 mil. USD 2,83 mld. Kč |
| 286 | Bioceltix BCX.WA | 90,40 PLN | +0,00 % | 133,31 mil. USD 2,82 mld. Kč |
| 287 |  Context Therapeutics CNTX | 1,45 USD | −0,34 % | 132,77 mil. USD 2,81 mld. Kč |
| 288 | Genelux GNLX | 2,96 USD | +2,78 % | 132,73 mil. USD 2,81 mld. Kč |
| 289 | Captor Therapeutics CTX.WA | 76,60 PLN | +0,00 % | 129,32 mil. USD 2,73 mld. Kč |
| 290 | Cibus CBUS | 1,49 USD | +2,76 % | 120,58 mil. USD 2,55 mld. Kč |
| 291 |  vTv Therapeutics VTVT | 30,46 USD | −0,72 % | 119,97 mil. USD 2,54 mld. Kč |
| 292 | Bioventix BVXP.L | 1 700,00 GBp | +0,00 % | 118,63 mil. USD 2,51 mld. Kč |
| 293 |  Inovio Pharmaceuticals INO | 1,36 USD | +1,49 % | 111,89 mil. USD 2,37 mld. Kč |
| 294 | Pyxis Oncology PYXS | 1,76 USD | +5,39 % | 111,51 mil. USD 2,36 mld. Kč |
| 295 | Actinogen Medical ACW.AX | 0,04 AUD | +0,00 % | 109,62 mil. USD 2,32 mld. Kč |
| 296 | Black Diamond Therapeutics BDTX | 1,87 USD | −1,84 % | 106,87 mil. USD 2,26 mld. Kč |
| 297 | Black Diamond Therapeutics BDTX | 1,87 USD | −1,84 % | 106,87 mil. USD 2,26 mld. Kč |
| 298 | Cognition Therapeutics CGTX | 1,17 USD | +3,54 % | 104,71 mil. USD 2,21 mld. Kč |
| 299 | Vivani Medical VANI | 1,21 USD | −3,20 % | 104,34 mil. USD 2,21 mld. Kč |
| 300 |  Seer SEER | 1,86 USD | −0,53 % | 102,27 mil. USD 2,16 mld. Kč |
| 301 | Seer SEER | 1,86 USD | −0,53 % | 102,27 mil. USD 2,16 mld. Kč |
| 302 |  Aldeyra Therapeutics ALDX | 1,69 USD | −2,03 % | 101,64 mil. USD 2,15 mld. Kč |
| 303 |  NRx Pharmaceuticals NRXP | 3,06 USD | +0,33 % | 101,19 mil. USD 2,14 mld. Kč |
| 304 | Recce Pharmaceuticals RCE.AX | 0,50 AUD | −0,99 % | 100,38 mil. USD 2,12 mld. Kč |
| 305 | Bioton BIO.WA | 4,31 PLN | +0,00 % | 98,65 mil. USD 2,09 mld. Kč |
| 306 | Biomea Fusion BMEA | 1,41 USD | +3,68 % | 98,33 mil. USD 2,08 mld. Kč |
| 307 | Neuraxis NRXS | 7,93 USD | −4,12 % | 98,20 mil. USD 2,08 mld. Kč |
| 308 |  Anixa Biosciences ANIX | 3,27 USD | +4,14 % | 97,90 mil. USD 2,07 mld. Kč |
| 309 | ProMIS Neurosciences PMN | 10,54 USD | +1,54 % | 94,52 mil. USD 2,00 mld. Kč |
| 310 | Dimerix DXB.AX | 0,22 AUD | +0,00 % | 91,70 mil. USD 1,94 mld. Kč |
| 311 |  iBio IBIO | 1,82 USD | −5,70 % | 90,41 mil. USD 1,91 mld. Kč |
| 312 | 4basebio 4BB.L | 435,00 GBp | +0,00 % | 89,96 mil. USD 1,90 mld. Kč |
| 313 | PolyPid PYPD | 4,62 USD | +1,09 % | 88,58 mil. USD 1,87 mld. Kč |
| 314 | Ryvu Therapeutics RVU.WA | 14,20 PLN | −0,56 % | 87,52 mil. USD 1,85 mld. Kč |
| 315 |  Adicet Bio ACET | 9,00 USD | +4,41 % | 84,13 mil. USD 1,78 mld. Kč |
| 316 | Annovis Bio ANVS | 1,92 USD | +1,05 % | 81,68 mil. USD 1,73 mld. Kč |
| 317 |  Gossamer Bio GOSS | 0,17 USD | −2,25 % | 80,76 mil. USD 1,71 mld. Kč |
| 318 |  Fortress Biotech FBIO | 2,39 USD | −0,42 % | 79,39 mil. USD 1,68 mld. Kč |
| 319 | Pliant Therapeutics PLRX | 1,26 USD | +0,80 % | 78,02 mil. USD 1,65 mld. Kč |
| 320 | Pliant Therapeutics PLRX | 1,26 USD | +0,80 % | 78,02 mil. USD 1,65 mld. Kč |
| 321 |  PMV Pharmaceuticals PMVP | 1,39 USD | −2,11 % | 74,13 mil. USD 1,57 mld. Kč |
| 322 | Gain Therapeutics GANX | 1,68 USD | −0,59 % | 71,66 mil. USD 1,52 mld. Kč |
| 323 |  BeyondSpring BYSI | 1,72 USD | +1,18 % | 70,73 mil. USD 1,50 mld. Kč |
| 324 |  XBiotech XBIT | 2,30 USD | +0,00 % | 70,12 mil. USD 1,48 mld. Kč |
| 325 | TScan Therapeutics TCRX | 1,07 USD | +9,17 % | 69,93 mil. USD 1,48 mld. Kč |
| 326 |  MediciNova MNOV | 1,39 USD | +1,46 % | 68,42 mil. USD 1,45 mld. Kč |
| 327 | Paradigm Biopharmaceuticals PAR.AX | 0,19 AUD | +8,82 % | 67,48 mil. USD 1,43 mld. Kč |
| 328 |  Cingulate CING | 4,65 USD | +2,65 % | 62,63 mil. USD 1,32 mld. Kč |
| 329 |  PDS Biotechnology PDSB | 1,10 USD | −15,38 % | 61,40 mil. USD 1,30 mld. Kč |
| 330 | Immutep IMM.AX | 0,06 AUD | +0,00 % | 59,34 mil. USD 1,25 mld. Kč |
| 331 | MiNK Therapeutics INKT | 11,81 USD | −5,78 % | 58,84 mil. USD 1,24 mld. Kč |
| 332 | Botanix Pharmaceuticals BOT.AX | 0,03 AUD | +0,00 % | 56,65 mil. USD 1,20 mld. Kč |
| 333 |  Xilio Therapeutics XLO | 8,22 USD | −2,43 % | 54,05 mil. USD 1,14 mld. Kč |
| 334 |  Instil Bio TIL | 7,73 USD | +0,52 % | 53,24 mil. USD 1,13 mld. Kč |
| 335 |  Sangamo Therapeutics SGMO | 0,12 USD | −8,23 % | 48,51 mil. USD 1,03 mld. Kč |
| 336 |  Atossa Therapeutics ATOS | 5,62 USD | +0,27 % | 48,35 mil. USD 1,02 mld. Kč |
| 337 |  Veru VERU | 3,01 USD | +2,38 % | 48,31 mil. USD 1,02 mld. Kč |
| 338 | Rallybio RLYB | 8,98 USD | +1,13 % | 47,50 mil. USD 1,00 mld. Kč |
| 339 | Mereo BioPharma MREO | 0,29 USD | −1,35 % | 46,61 mil. USD 985,52 mil. Kč |
| 340 | Cynata Therapeutics CYP.AX | 0,28 AUD | +5,77 % | 46,48 mil. USD 982,73 mil. Kč |
| 341 |  Dare Bioscience DARE | 3,11 USD | +32,91 % | 45,28 mil. USD 957,42 mil. Kč |
| 342 | Genenta Science S.p.A. GNTA | 1,87 USD | −2,60 % | 44,12 mil. USD 932,79 mil. Kč |
| 343 | RenovoRx RNXT | 0,96 USD | −2,53 % | 43,08 mil. USD 910,88 mil. Kč |
| 344 | Sareum SAR.L | 21,50 GBp | +7,50 % | 39,79 mil. USD 841,33 mil. Kč |
| 345 | Aligos Therapeutics ALGS | 6,23 USD | +3,32 % | 38,55 mil. USD 815,19 mil. Kč |
| 346 |  NanoViricides NNVC | 1,74 USD | +1,16 % | 37,58 mil. USD 794,51 mil. Kč |
| 347 | Evaxion Biotech EVAX | 4,50 USD | +1,93 % | 37,49 mil. USD 792,69 mil. Kč |
| 348 | Sernova SVA.TO | 0,14 CAD | +0,00 % | 37,23 mil. USD 787,29 mil. Kč |
| 349 | Prescient Therapeutics PTX.AX | 0,07 AUD | +1,49 % | 37,23 mil. USD 787,17 mil. Kč |
| 350 | Covalon Technologies COV.V | 2,08 CAD | +0,00 % | 37,15 mil. USD 785,51 mil. Kč |
| 351 | Medicenna Therapeutics MDNA.TO | 0,62 CAD | +0,00 % | 36,42 mil. USD 770,17 mil. Kč |
| 352 | Arecor Therapeutics AREC.L | 70,00 GBp | +6,06 % | 35,30 mil. USD 746,39 mil. Kč |
| 353 |  Kala Pharmaceuticals KALA | 1,78 USD | +2,89 % | 33,09 mil. USD 699,67 mil. Kč |
| 354 | Cervomed CRVO | 3,55 USD | −3,79 % | 32,87 mil. USD 694,99 mil. Kč |
| 355 | Mabion MAB.WA | 7,58 PLN | +5,28 % | 32,66 mil. USD 690,52 mil. Kč |
| 356 | Senti Biosciences SNTI | 1,02 USD | +10,28 % | 31,77 mil. USD 671,71 mil. Kč |
| 357 |  Outlook Therapeutics OTLK | 0,26 USD | +4,88 % | 31,66 mil. USD 669,41 mil. Kč |
| 358 |  Actinium Pharmaceuticals ATNM | 1,01 USD | +1,52 % | 31,53 mil. USD 666,73 mil. Kč |
| 359 | Apollomics APLM | 14,15 USD | +0,64 % | 31,07 mil. USD 657,05 mil. Kč |
| 360 | Molecure MOC.WA | 6,04 PLN | +3,78 % | 30,76 mil. USD 650,32 mil. Kč |
| 361 | Imugene IMU.AX | 0,11 AUD | −8,70 % | 30,49 mil. USD 644,71 mil. Kč |
| 362 | Werewolf Therapeutics HOWL | 0,62 USD | −4,64 % | 30,13 mil. USD 637,08 mil. Kč |
| 363 |  India Globalization Capital IGC | 0,30 USD | −2,57 % | 29,94 mil. USD 632,97 mil. Kč |
| 364 | Lisata Therapeutics LSTA | 3,15 USD | −2,48 % | 28,69 mil. USD 606,53 mil. Kč |
| 365 | Proteomics International Laboratories PIQ.AX | 0,25 AUD | +6,38 % | 28,67 mil. USD 606,16 mil. Kč |
| 366 | NeuroSense Therapeutics NRSN | 0,71 USD | −2,07 % | 28,39 mil. USD 600,28 mil. Kč |
| 367 | BriaCell Therapeutics BCT.TO | 5,55 CAD | −2,97 % | 28,34 mil. USD 599,22 mil. Kč |
| 368 | PolTREG PTG.WA | 19,35 PLN | +2,93 % | 28,01 mil. USD 592,19 mil. Kč |
| 369 | Barinthus Biotherapeutics BRNS | 0,69 USD | +2,24 % | 27,98 mil. USD 591,65 mil. Kč |
| 370 | Barinthus Biotherapeutics BRNS | 0,69 USD | +2,24 % | 27,98 mil. USD 591,65 mil. Kč |
| 371 | Harvard Apparatus Regenerative Technology HRGN | 1,55 USD | +0,00 % | 27,25 mil. USD 576,19 mil. Kč |
| 372 | MedMira MIR.V | 0,06 CAD | +0,00 % | 27,18 mil. USD 574,72 mil. Kč |
| 373 | Jasper Therapeutics JSPR | 0,94 USD | +1,72 % | 26,38 mil. USD 557,76 mil. Kč |
| 374 |  Celularity CELU | 0,91 USD | −2,42 % | 26,27 mil. USD 555,43 mil. Kč |
| 375 | Celularity CELU | 0,91 USD | −2,42 % | 26,27 mil. USD 555,43 mil. Kč |
| 376 |  Palatin Technologies PTN | 14,34 USD | +6,22 % | 25,51 mil. USD 539,50 mil. Kč |
| 377 | Pluri PLUR | 2,27 USD | +0,89 % | 24,49 mil. USD 517,88 mil. Kč |
| 378 | Microbix Biosystems MBX.TO | 0,30 CAD | +0,00 % | 24,44 mil. USD 516,74 mil. Kč |
| 379 |  Longeveron LGVN | 0,77 USD | +0,12 % | 24,37 mil. USD 515,19 mil. Kč |
| 380 |  Lantern Pharma LTRN | 2,13 USD | +1,43 % | 24,08 mil. USD 509,14 mil. Kč |
| 381 |  VYNE Therapeutics VYNE | 0,64 USD | +0,68 % | 21,21 mil. USD 448,54 mil. Kč |
| 382 | Arch Biopartners ARCH.V | 0,44 CAD | +6,10 % | 20,81 mil. USD 440,04 mil. Kč |
| 383 | Nanogroup NNG.WA | 2,40 PLN | −0,83 % | 20,58 mil. USD 435,11 mil. Kč |
| 384 | Quince Therapeutics QNCX | 1,05 USD | −5,41 % | 20,54 mil. USD 434,25 mil. Kč |
| 385 | Pasithea Therapeutics KTTA | 0,59 USD | −2,78 % | 19,75 mil. USD 417,63 mil. Kč |
| 386 | Devonian Health GSD.V | 10,00 CAD | +0,00 % | 19,58 mil. USD 414,10 mil. Kč |
| 387 | Aeon Biopharma AEON | 0,74 USD | +0,79 % | 19,40 mil. USD 410,13 mil. Kč |
| 388 | Anebulo Pharmaceuticals ANEB | 0,47 USD | +0,00 % | 19,17 mil. USD 405,32 mil. Kč |
| 389 |  Lipocine LPCN | 2,26 USD | +2,73 % | 18,63 mil. USD 393,96 mil. Kč |
| 390 | Sensei Biotherapeutics SNSE | 13,85 USD | +0,00 % | 18,59 mil. USD 392,99 mil. Kč |
| 391 | Passage Bio PASG | 5,57 USD | +1,27 % | 17,87 mil. USD 377,80 mil. Kč |
| 392 |  Tempest Therapeutics TPST | 1,09 USD | −1,80 % | 17,42 mil. USD 368,29 mil. Kč |
| 393 |  Citius Pharmaceuticals CTXR | 0,63 USD | −1,45 % | 17,31 mil. USD 366,04 mil. Kč |
| 394 | Seastar Medical ICU | 4,92 USD | +1,23 % | 16,55 mil. USD 349,89 mil. Kč |
| 395 | Cadrenal Therapeutics CVKD | 5,27 USD | −0,75 % | 16,22 mil. USD 343,01 mil. Kč |
| 396 |  Cel-Sci CVM | 1,11 USD | −5,93 % | 16,09 mil. USD 340,16 mil. Kč |
| 397 | IN8bio INAB | 1,42 USD | +0,00 % | 14,87 mil. USD 314,40 mil. Kč |
| 398 |  Curis CRIS | 0,38 USD | −8,61 % | 14,81 mil. USD 313,19 mil. Kč |
| 399 | Hookipa Pharma HOOK | 1,15 USD | +0,00 % | 14,23 mil. USD 300,95 mil. Kč |
| 400 | CytoMed Therapeutics GDTC | 1,14 USD | +6,54 % | 13,49 mil. USD 285,23 mil. Kč |
| 401 |  Cyclerion Therapeutics CYCN | 3,12 USD | −1,11 % | 13,49 mil. USD 285,22 mil. Kč |
| 402 |  Cocrystal Pharma COCP | 0,97 USD | +2,66 % | 13,39 mil. USD 283,19 mil. Kč |
| 403 |  Phio Pharmaceuticals PHIO | 1,00 USD | +0,00 % | 11,62 mil. USD 245,64 mil. Kč |
| 404 | Theriva Biologics TOVX | 0,25 USD | +0,16 % | 11,52 mil. USD 243,56 mil. Kč |
| 405 | Neurotech International NTI.AX | 0,01 AUD | +0,00 % | 10,98 mil. USD 232,11 mil. Kč |
| 406 |  Quoin Pharmaceuticals Ltd. QNRX | 4,58 USD | −2,76 % | 10,70 mil. USD 226,15 mil. Kč |
| 407 | Kiora Pharmaceuticals KPRX | 2,63 USD | −1,13 % | 10,31 mil. USD 218,09 mil. Kč |
| 408 |  Aprea Therapeutics APRE | 0,74 USD | −0,55 % | 10,26 mil. USD 216,96 mil. Kč |
| 409 | Pharmena PHR.WA | 3,38 PLN | −2,03 % | 10,04 mil. USD 212,19 mil. Kč |
| 410 |  Intensity Therapeutics INTS | 3,71 USD | −5,60 % | 10,03 mil. USD 212,03 mil. Kč |
| 411 |  VistaGen Therapeutics VTGN | 0,24 USD | +7,52 % | 9,97 mil. USD 210,83 mil. Kč |
| 412 | Calcimedica CALC | 0,59 USD | +0,57 % | 9,22 mil. USD 194,88 mil. Kč |
| 413 |  AIM ImmunoTech AIM | 0,31 USD | −12,18 % | 8,65 mil. USD 182,96 mil. Kč |
| 414 |  Synlogic SYBX | 0,68 USD | +1,49 % | 7,95 mil. USD 168,18 mil. Kč |
| 415 | Pure Biologics Spólka Akcyjna PUR.WA | 2,43 PLN | −2,80 % | 7,93 mil. USD 167,71 mil. Kč |
| 416 | Imunon IMNN | 1,88 USD | −3,59 % | 7,90 mil. USD 167,04 mil. Kč |
| 417 | Nymox Pharmaceutical NYMXF | 0,08 USD | −8,02 % | 7,83 mil. USD 165,48 mil. Kč |
| 418 |  Can Fite Biopharma CANF | 3,46 USD | −2,24 % | 7,41 mil. USD 156,75 mil. Kč |
| 419 | Bolt Biotherapeutics BOLT | 3,85 USD | −1,41 % | 7,40 mil. USD 156,43 mil. Kč |
| 420 |  BrainStorm Cell Therapeutics BCLI | 0,67 USD | −3,90 % | 7,39 mil. USD 156,33 mil. Kč |
| 421 | TransCode Therapeutics RNAZ | 8,01 USD | −4,64 % | 7,34 mil. USD 155,30 mil. Kč |
| 422 | HCW Biologics HCWB | 4,58 USD | −8,22 % | 7,31 mil. USD 154,64 mil. Kč |
| 423 | Eterna Therapeutics ERNA | 6,15 USD | −6,18 % | 7,17 mil. USD 151,67 mil. Kč |
| 424 |  Genprex GNPX | 0,62 USD | −1,81 % | 6,83 mil. USD 144,31 mil. Kč |
| 425 |  Aptorum Group APM | 0,83 USD | −4,36 % | 6,78 mil. USD 143,28 mil. Kč |
| 426 |  NuCana NCNA | 1,58 USD | +4,54 % | 6,58 mil. USD 139,04 mil. Kč |
| 427 | Acurx Pharmaceuticals ACXP | 1,53 USD | −1,30 % | 6,58 mil. USD 139,04 mil. Kč |
| 428 | Moolec Science MLEC | 8,90 USD | −0,89 % | 6,46 mil. USD 136,65 mil. Kč |
| 429 | BioAtla BCAB | 3,34 USD | −4,44 % | 5,53 mil. USD 117,03 mil. Kč |
| 430 | BioAtla BCAB | 3,34 USD | −4,44 % | 5,53 mil. USD 117,03 mil. Kč |
| 431 |  Alaunos Therapeutics TCRT | 2,23 USD | +0,45 % | 5,45 mil. USD 115,15 mil. Kč |
| 432 | Cardio Diagnostics CDIO | 1,99 USD | −5,69 % | 5,39 mil. USD 113,89 mil. Kč |
| 433 |  Adial Pharmaceuticals ADIL | 2,40 USD | −5,14 % | 5,14 mil. USD 108,78 mil. Kč |
| 434 | Dermata Therapeutics DRMA | 1,34 USD | −2,90 % | 5,07 mil. USD 107,16 mil. Kč |
| 435 |  Galmed Pharmaceuticals GLMD | 0,75 USD | +11,23 % | 4,97 mil. USD 105,16 mil. Kč |
| 436 |  Pulmatrix PULM | 1,25 USD | −3,63 % | 4,57 mil. USD 96,53 mil. Kč |
| 437 | Alzamend Neuro ALZN | 1,15 USD | +0,00 % | 4,38 mil. USD 92,52 mil. Kč |
| 438 | XORTX Therapeutics XRTX | 2,76 USD | −0,36 % | 4,27 mil. USD 90,28 mil. Kč |
| 439 | Aptose Biosciences APS.TO | 2,40 CAD | +0,00 % | 4,21 mil. USD 88,94 mil. Kč |
| 440 | Revelation Biosciences REVB | 1,13 USD | −1,74 % | 4,20 mil. USD 88,89 mil. Kč |
| 441 |  Matinas BioPharma MTNB | 0,64 USD | −0,78 % | 4,10 mil. USD 86,69 mil. Kč |
| 442 | 60 Degrees Pharmaceuticals SXTP | 1,53 USD | +5,52 % | 4,07 mil. USD 86,03 mil. Kč |
| 443 | Futura Medical FUM.L | 0,50 GBp | −12,85 % | 3,90 mil. USD 82,41 mil. Kč |
| 444 | Calidi Biotherapeutics CLDI | 0,22 USD | −8,69 % | 3,30 mil. USD 69,68 mil. Kč |
| 445 |  Soligenix SNGX | 0,31 USD | −6,89 % | 3,18 mil. USD 67,16 mil. Kč |
| 446 | Gri Bio GRI | 1,87 USD | +6,25 % | 3,15 mil. USD 66,61 mil. Kč |
| 447 | Azitra AZTR | 0,17 USD | +0,78 % | 2,70 mil. USD 57,18 mil. Kč |
| 448 |  Oragenics OGEN | 0,57 USD | +0,12 % | 2,57 mil. USD 54,45 mil. Kč |
| 449 |  Hepion Pharmaceuticals HEPA | 0,09 USD | −3,30 % | 2,56 mil. USD 54,18 mil. Kč |
| 450 | Biodexa Pharmaceuticals BDRX | 3,75 USD | +1,81 % | 2,43 mil. USD 51,41 mil. Kč |
| 451 |  Jaguar Health JAGX | 3,55 USD | +7,90 % | 2,33 mil. USD 49,34 mil. Kč |
| 452 | Scinai Immunotherapeutics SCNI | 0,54 USD | −4,72 % | 1,92 mil. USD 40,62 mil. Kč |
| 453 |  Vaxxinity VAXX | 0,02 USD | +0,00 % | 1,90 mil. USD 40,21 mil. Kč |
| 454 | Zyversa Therapeutics ZVSA | 0,19 USD | −4,95 % | 1,54 mil. USD 32,54 mil. Kč |
| 455 | Lyra Therapeutics LYRA | 0,73 USD | −5,99 % | 1,30 mil. USD 27,40 mil. Kč |
| 456 |  Evofem Biosciences EVFM | 0,01 USD | −11,11 % | 1,19 mil. USD 25,22 mil. Kč |
| 457 | Aditx Therapeutics ADTX | 0,20 USD | +0,05 % | 176 461 USD 3,73 mil. Kč |
| 458 | Aditx Therapeutics ADTX | 0,20 USD | +0,05 % | 176 461 USD 3,73 mil. Kč |
| 459 | Ocean Biomedical OCEA | 0,00 USD | −33,33 % | 46 473 USD 982 648 Kč |
| 460 | Carisma Therapeutics CARM | 0,01 USD | +5,17 % | 41 845 USD 884 792 Kč |
| 461 | Scopus Biopharma SCPS | 0,00 USD | +50,00 % | 25 250 USD 533 899 Kč |
| 462 | Virpax Pharmaceuticals VRPX | 0,01 USD | +0,00 % | 13 791 USD 291 604 Kč |
| 463 |  Ampio Pharmaceuticals AMPE | 0,18 USD | +0,00 % | 5 903 USD 124 816 Kč |
| 464 | Better Therapeutics BTTX | 0,00 USD | +0,00 % | 5 451 USD 115 259 Kč |
| 465 | COMERA LIFE SCIENCES HOLDINGS CMRA | 0,00 USD | +0,00 % | 3 073 USD 64 977 Kč |
| 466 |  Syros Pharmaceuticals SYRS | 0,00 USD | +0,00 % | 2 683 USD 56 731 Kč |
| 467 | Effector Therapeutics EFTR | 0,00 USD | +0,00 % | 2 352 USD 49 732 Kč |
| 468 | NexImmune NEXI | 0,00 USD | +0,00 % | 139 USD 2 939 Kč |
| 469 | Theratechnologies THTX | 3,39 USD | +0,00 % | – |
| 470 | Genfit GNFTP.XD | 12,84 EUR | +22,52 % | – |
Hledané společnosti nic neodpovídá.
Upozornění: Uvedená data jsou poskytována výhradně pro informativní účely. Navzdory naší snaze o co největší přesnost mohou obsahovat chyby nebo být neaktuální. Důrazně doporučujeme ověřit tato data z dalších nezávislých zdrojů. Na základě těchto dat by neměla být činěna žádná rozhodnutí.